EADV 2026 视频特辑｜史玉玲教授：精准银屑病治疗：患者分层与分子标志物

史玉玲教授指出，随着生物制剂与小分子药物不断涌现，未来银屑病治疗的关键在于精准化：依据合并症、治疗史、依从性与患者意愿进行分层，并借助分子标志物预测个体疗效反应；中国研究者可在人群分层与高质量证据产出方面，为全球银屑病领域贡献力量。
Professor Shi Yuling noted that with the growing availability of biologics and small-molecule therapies, precision will be central to the future of psoriasis treatment. This entails stratifying patients according to comorbidities, treatment history, treatment adherence and patient preferences, and leveraging molecular biomarkers to predict individual treatment responses. Chinese researchers can make valuable contributions to the global psoriasis field through population stratification efforts and the generation of high-quality clinical evidence.